These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 30695232)
1. Lipid phosphatases SKIP and SHIP2 regulate fibronectin-dependent cell migration in glioblastoma. Ramos AR; Ghosh S; Dedobbeleer M; Robe PA; Rogister B; Erneux C FEBS J; 2019 Mar; 286(6):1120-1135. PubMed ID: 30695232 [TBL] [Abstract][Full Text] [Related]
2. Phosphoinositide 5-phosphatases SKIP and SHIP2 in ruffles, the endoplasmic reticulum and the nucleus: An update. Ramos AR; Ghosh S; Suhel T; Chevalier C; Obeng EO; Fafilek B; Krejci P; Beck B; Erneux C Adv Biol Regul; 2020 Jan; 75():100660. PubMed ID: 31628071 [TBL] [Abstract][Full Text] [Related]
3. Phosphoinositide 5-phosphatase activities control cell motility in glioblastoma: Two phosphoinositides PI(4,5)P2 and PI(3,4)P2 are involved. Ramos AR; Elong Edimo W; Erneux C Adv Biol Regul; 2018 Jan; 67():40-48. PubMed ID: 28916189 [TBL] [Abstract][Full Text] [Related]
4. SHIP2 controls plasma membrane PI(4,5)P2 thereby participating in the control of cell migration in 1321 N1 glioblastoma cells. Elong Edimo W; Ghosh S; Derua R; Janssens V; Waelkens E; Vanderwinden JM; Robe P; Erneux C J Cell Sci; 2016 Mar; 129(6):1101-14. PubMed ID: 26826186 [TBL] [Abstract][Full Text] [Related]
5. The SHIP2 interactor Myo1c is required for cell migration in 1321 N1 glioblastoma cells. Edimo WE; Ramos AR; Ghosh S; Vanderwinden JM; Erneux C Biochem Biophys Res Commun; 2016 Aug; 476(4):508-514. PubMed ID: 27246739 [TBL] [Abstract][Full Text] [Related]
6. Silencer of death domains (SODD) inhibits skeletal muscle and kidney enriched inositol 5-phosphatase (SKIP) and regulates phosphoinositide 3-kinase (PI3K)/Akt signaling to the actin cytoskeleton. Rahman P; Huysmans RD; Wiradjaja F; Gurung R; Ooms LM; Sheffield DA; Dyson JM; Layton MJ; Sriratana A; Takada H; Tiganis T; Mitchell CA J Biol Chem; 2011 Aug; 286(34):29758-70. PubMed ID: 21712384 [TBL] [Abstract][Full Text] [Related]
7. Differential SKIP expression in PTEN-deficient glioblastoma regulates cellular proliferation and migration. Davies EM; Kong AM; Tan A; Gurung R; Sriratana A; Bukczynska PE; Ooms LM; McLean CA; Tiganis T; Mitchell CA Oncogene; 2015 Jul; 34(28):3711-27. PubMed ID: 25241900 [TBL] [Abstract][Full Text] [Related]
8. SHIP2 regulates epithelial cell polarity through its lipid product, which binds to Dlg1, a pathway subverted by hepatitis C virus core protein. Awad A; Sar S; Barré R; Cariven C; Marin M; Salles JP; Erneux C; Samuel D; Gassama-Diagne A Mol Biol Cell; 2013 Jul; 24(14):2171-85. PubMed ID: 23699395 [TBL] [Abstract][Full Text] [Related]
9. PTEN and Other PtdIns(3,4,5)P Csolle MP; Ooms LM; Papa A; Mitchell CA Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276499 [TBL] [Abstract][Full Text] [Related]
10. Src family tyrosine kinases regulate adhesion-dependent tyrosine phosphorylation of 5'-inositol phosphatase SHIP2 during cell attachment and spreading on collagen I. Prasad N; Topping RS; Decker SJ J Cell Sci; 2002 Oct; 115(Pt 19):3807-15. PubMed ID: 12235291 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of SHIP2 activity inhibits cell migration and could prevent metastasis in breast cancer cells. Ghosh S; Scozzaro S; Ramos AR; Delcambre S; Chevalier C; Krejci P; Erneux C J Cell Sci; 2018 Aug; 131(16):. PubMed ID: 30012834 [TBL] [Abstract][Full Text] [Related]
12. Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activation. Hoekstra E; Das AM; Willemsen M; Swets M; Kuppen PJ; van der Woude CJ; Bruno MJ; Shah JP; Ten Hagen TL; Chisholm JD; Kerr WG; Peppelenbosch MP; Fuhler GM Oncotarget; 2016 Nov; 7(45):73525-73540. PubMed ID: 27716613 [TBL] [Abstract][Full Text] [Related]
13. Fibroblasts derived from patients with opsismodysplasia display SHIP2-specific cell migration and adhesion defects. Ghosh S; Huber C; Siour Q; Sousa SB; Wright M; Cormier-Daire V; Erneux C Hum Mutat; 2017 Dec; 38(12):1731-1739. PubMed ID: 28869677 [TBL] [Abstract][Full Text] [Related]
14. SHIP2 signalling at the plasma membrane, in the nucleus and at focal contacts. Elong Edimo W; Vanderwinden JM; Erneux C Adv Biol Regul; 2013 Jan; 53(1):28-37. PubMed ID: 23040614 [TBL] [Abstract][Full Text] [Related]
15. SHIP2 signaling in normal and pathological situations: Its impact on cell proliferation. Elong Edimo W; Schurmans S; Roger PP; Erneux C Adv Biol Regul; 2014 Jan; 54():142-51. PubMed ID: 24091101 [TBL] [Abstract][Full Text] [Related]
16. The association between the SH2-containing inositol polyphosphate 5-Phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners. Onnockx S; De Schutter J; Blockmans M; Xie J; Jacobs C; Vanderwinden JM; Erneux C; Pirson I J Cell Physiol; 2008 Jan; 214(1):260-72. PubMed ID: 17620296 [TBL] [Abstract][Full Text] [Related]
17. The influence of anionic lipids on SHIP2 phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase activity. Vandeput F; Backers K; Villeret V; Pesesse X; Erneux C Cell Signal; 2006 Dec; 18(12):2193-9. PubMed ID: 16824732 [TBL] [Abstract][Full Text] [Related]
18. Aβ modulates actin cytoskeleton via SHIP2-mediated phosphoinositide metabolism. Lee HN; Sim KM; Kim H; Ju J; Pae AN; Park JB; Ryu H; Seong J Sci Rep; 2019 Oct; 9(1):15557. PubMed ID: 31664099 [TBL] [Abstract][Full Text] [Related]
19. Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity. Sasaoka T; Wada T; Tsuneki H Pharmacol Ther; 2006 Dec; 112(3):799-809. PubMed ID: 16842857 [TBL] [Abstract][Full Text] [Related]
20. IRTKS Promotes Insulin Signaling Transduction through Inhibiting SHIP2 Phosphatase Activity. Wu C; Cui X; Huang L; Shang X; Wu B; Wang N; He K; Han Z Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]